Something went wrong! Please try again later.
Don't have an account? Click here to register
Get access to regular updates from PE HUB
Which other brands would you like to receive newsletters from:
A link has been emailed to you - check your inbox.
ATAI Life Sciences, a global biotech platform focused on curing mental health disorders, has raised $43 million in Series B financing. Subversive Capital led the round.
Source: Press Release